Beth Karlan is an Oncology physician affiliated with Cedars-Sinai Medical Center. OpenAlex indexes 1,130 publications with 110,663 citations (h-index 129); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 1% of Gynecologic Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Ucla Medical Plz Ste 430
Los Angeles, CA 90095
Telephone
310-794-7274Registry record last updated 7 Oct 2019.
Clinical trials
- A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women
Sponsor: Fred Hutchinson Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Pacira Pharmaceuticals IncorporatedProgram year20241 payment
- Foundation Medicine, Inc.Program year20232 payments
- Seagen Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
3 NIH research awards on record, funded 1991–2026 per NIH RePORTER. The latest:
- Patient Centered Outcomes Research Training in Urologic and Gynecologic Cancers (PCORT UroGynCan)
University of California Los Angeles
FY2026$457,856T32CA251072 - BLOOD AND TISSUE BANKING IN GYNECOLOGICAL MALIGNANCIES
Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
FY2008$2,193M01RR000425 - BLOOD AND TISSUE BANKING IN GYNECOLOGICAL MALIGNANCIES
Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
FY2007$3,347M01RR000425
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Raj Makkar, MD
Cedars-Sinai Medical Center
Paul Noble, MD
Cedars-Sinai Medical Center
Stephen Freedland, MD
Cedars-Sinai Medical Center
Jon Kobashigawa, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”